Just three months ago I wrote two articles about the attention being paid to the skyrocketing costs of generics. Now, it seems, that outrage has been displaced by concerns over the high cost of specialty drugs that treat Hepatitis C, HIV, and Cancer.
This week, I’m taking a break from the latest independent pharmacy news to share some great news about how TRxADE will be able to help you even more moving forward. Some of these items are in the planning stage, while others are already in place.
And the very first item is that we want to meet you! Read more
Two complementary bills introduced the same day
On January 29th, bills were introduced in both the U.S. Senate and House of Representatives to “provide for coverage under the Medicare program of pharmacist services.”
If passed and signed into law, patients in underserved areas would have access to Medication Therapy Management from pharmacists who would receive Medicare reimbursement as providers. Read more
While many in the public and private sectors proclaim their passion for reshaping our healthcare system to be more efficient, less expensive, and provide better outcomes, it often seems that the “innovations” introduced leave independent pharmacies holding the bag – or, to be more precise, paying the bill – while patients suffer the consequences.
Follow us on Facebook
- Antimicrobial Resistance Information from FDA July 5, 2022Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.FDA
- Seagen touts new Tukysa colorectal cancer data, setting up FDA filing and a potential $500M opportunity July 5, 2022Seagen touts new Tukysa colorectal cancer data, setting up FDA filing and a potential $500M opportunity zbecker Tue, 07/05/2022 - 11:16zbecker
2420 Brunello Trace
Lutz, Florida 33558
9am-5pm Mon-Fri EST
Click Here For Contact Request Form